[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
November 24, 1951


Author Affiliations

Chairman Division of Medical Sciences National Research Council 2101 Constitution Ave. Washington 25, D. C.

JAMA. 1951;147(13):1297. doi:10.1001/jama.1951.03670300111027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —At the Oct. 12, 1951, meeting of the Committee on Cancer Diagnosis and Therapy, the following opinion regarding "krebiozen" was formulated:The Committee on Cancer Diagnosis and Therapy has reviewed available data on the effects of a secret preparation called "krebiozen" in the treatment of a large number of cases of cancer. The preparation was used as directed in the original publication of Drs. Durovic and Ivy. The Committee finds no evidence of any curative effect, and no proof of palliative effect attributable to the "drug" itself.This opinion is based on examination of (a) the original booklet presented by the head of the Department of Clinical Science of the University of Illinois in March, 1951; (b) a summary of 63 cases reviewed by the staff of the Committee; and (c) an analysis of 100 cases prepared by a study committee of the American Medical Association, which

First Page Preview View Large
First page PDF preview
First page PDF preview